TY - JOUR
T1 - Follow-up of the Post-Liver Transplantation Patient
T2 - A Primer for the Practicing Gastroenterologist
AU - Cheung, Amanda
AU - Levitsky, Josh
N1 - Funding Information:
Disclosure: Advisor and stock holder for Transplant Genomics Incorporated; Speaker for Gilead, Salix, Novartis; Research grants from Novartis, Abbvie (J. Levitsky). A. Cheung has nothing to disclose.
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/11
Y1 - 2017/11
N2 - The focus in liver transplantation in the next 10 years will likely change from preventing viral disease recurrence to minimizing the toll of rejection and fatty liver disease, minimizing the complications from immunosuppression with withdrawal strategies, and more optimal management of long-term risks, such as malignancy, cardiovascular disease, and renal failure. In addition, now that short-term results (<1 year) have improved significantly, there will be a shift toward improving long-term patient and graft survival, as well as a focus on primary care preventive strategies.
AB - The focus in liver transplantation in the next 10 years will likely change from preventing viral disease recurrence to minimizing the toll of rejection and fatty liver disease, minimizing the complications from immunosuppression with withdrawal strategies, and more optimal management of long-term risks, such as malignancy, cardiovascular disease, and renal failure. In addition, now that short-term results (<1 year) have improved significantly, there will be a shift toward improving long-term patient and graft survival, as well as a focus on primary care preventive strategies.
KW - Immunosuppression
KW - Liver transplantation
KW - Outcomes
KW - Prophylaxis
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85027287476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027287476&partnerID=8YFLogxK
U2 - 10.1016/j.cld.2017.06.006
DO - 10.1016/j.cld.2017.06.006
M3 - Review article
C2 - 28987263
AN - SCOPUS:85027287476
SN - 1089-3261
VL - 21
SP - 793
EP - 813
JO - Clinics in liver disease
JF - Clinics in liver disease
IS - 4
ER -
